Can Herbalife Overcome This Quarter?

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Can Herbalife Overcome This Quarter?

© Wikimedia Commons

Herbalife Nutrition Ltd. (NYSE: HLF) is set to report its most recent quarterly results after the markets close on Tuesday. Consensus estimates are calling for $0.61 in earnings per share (EPS) and revenue of $1.19 billion. The fourth quarter of last year reportedly had EPS of $0.65 and $1.09 billion in revenue.

Early in January, the firm announced that CEO Richard Goudis will be resigning. Those close to the matter say that the departure is a result of comments Goudis made before he became chief executive. The company did not release any details about the exact comments but said at the time that they were unrelated to Herbalife’s financial reporting.

This company has been under fire for years after being called a pyramid scheme by Pershing Square’s Bill Ackman, with none other than Carl Icahn coming to Herbalife’s aid. Since then, Ackman has stopped his bet against Herbalife, and Icahn has been selling his shares and taking a reduced stake in the firm.

Michael O. Johnson, the Herbalife’s executive chair, who led the company as its CEO from 2003 to 2017, will reassume the role of CEO on an interim basis following the resignation of Goudis. The board of directors expects to select the permanent CEO from the company’s senior leadership team.

[nativounit]

At the same time, Herbalife announced preliminary volume point results for the fourth quarter 2018, which were up 11.6% worldwide year over year, and reaffirmed its initial full-year 2019 guidance as announced on October 30, 2018.

Over the past 52 weeks, Herbalife has outperformed the broad markets, with the stock up about 36%. However, in just 2019 alone, the stock is down closer to 4%.

Shares of Herbalife were last seen up about 1% at $57.44 on Tuesday, in a 52-week range of $41.28 to $61.77 and with a consensus price target of $62.60.

[recirclink id=527115]

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618